Pleural Effusion Secondary to Dasatinib Following Allogenic Hematopoietic Stem Cell Transplantation

Riyadh R. Alrubaye; Celine A. Fadel; Comfort Y. Adewunmi; Loida Del Rio Lopez

doi:10.12659/AJCR.932711

07 August 2021 : Case report USA

Pleural Effusion Secondary to Dasatinib Following Allogenic Hematopoietic Stem Cell Transplantation

Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Unusual setting of medical care, Rare disease, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)

Riyadh R. Alrubaye^1ABCDEF*, Celine A. Fadel^2DEF, Comfort Y. Adewunmi^2ABCD, Loida Del Rio Lopez^2ABF

DOI: 10.12659/AJCR.932711

Am J Case Rep 2021; 22:e932711

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 4. After bilateral thoracentesis, a chest X-ray on the discharge date showed complete resolution of the right pleural effusion.

Back to the Article

Pleural Effusion Secondary to Dasatinib Following Allogenic Hematopoietic Stem Cell Transplantation

Your Privacy